Founders Financial Securities’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,586
| Closed | -$37.5K | – | 439 |
|
|
2024
Q3 | $37.5K | Buy |
+11,586
| New | +$37.5K | ﹤0.01% | 418 |
|
|
2024
Q2 | – | Sell |
-10,333
| Closed | -$60.8K | – | 427 |
|
|
2024
Q1 | $60.8K | Hold |
10,333
| – | – | 0.01% | 376 |
|
|
2023
Q4 | $38.3K | Hold |
10,333
| – | – | ﹤0.01% | 360 |
|
|
2023
Q3 | $57.3K | Buy |
10,333
+833
| +9% | +$4.62K | 0.01% | 320 |
|
|
2023
Q2 | $104K | Hold |
9,500
| – | – | 0.01% | 310 |
|
|
2023
Q1 | $119K | Hold |
9,500
| – | – | 0.02% | 307 |
|
|
2022
Q4 | $94.6K | Sell |
9,500
-19,485
| -67% | -$194K | 0.01% | 312 |
|
|
2022
Q3 | $5.27M | Buy |
28,985
+20,360
| +236% | +$3.7M | 0.93% | 20 |
|
|
2022
Q2 | $127K | Buy |
+8,625
| New | +$127K | 0.02% | 251 |
|
|
2022
Q1 | – | Sell |
-8,625
| Closed | -$207K | – | 262 |
|
|
2021
Q4 | $207K | Buy |
8,625
+417
| +5% | +$10K | 0.04% | 248 |
|
|
2021
Q3 | $164K | Hold |
8,208
| – | – | 0.03% | 248 |
|
|
2021
Q2 | $186K | Buy |
8,208
+4,041
| +97% | +$91.6K | 0.04% | 285 |
|
|
2021
Q1 | $84K | Hold |
4,167
| – | – | 0.02% | 254 |
|
|
2020
Q4 | $67K | Hold |
4,167
| – | – | 0.02% | 225 |
|
|
2020
Q3 | $50K | Sell |
4,167
-3,958
| -49% | -$47.5K | 0.02% | 157 |
|
|
2020
Q2 | $102K | Buy |
8,125
+6,458
| +387% | +$81.1K | 0.03% | 167 |
|
|
2020
Q1 | $17K | Buy |
+1,667
| New | +$17K | 0.01% | 126 |
|
|
2019
Q4 | – | Sell |
-1,667
| Closed | -$16K | – | 125 |
|
|
2019
Q3 | $16K | Hold |
1,667
| – | – | 0.01% | 131 |
|
|
2019
Q2 | $17K | Buy |
+1,667
| New | +$17K | 0.01% | 114 |
|